Microbix Biosystems (TSX:MBX) FFO


TSX:MBX Microbix Biosystems Inc TSX:MBX
52 GF Score
Price C$0.31
GF Value C$0.24
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems FFO?

FFO (Funds from operations) only applies to REITs.

TSX:MBX
52GF Score
Microbix Biosystems Inc TSX:MBX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Microbix Biosystems (TSX:MBX) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of C$0.31 is trading 27.1% above its estimated GF Value™ of C$0.24. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for TSX:MBX:

  • FFO:
  • GF Value™: C$0.24 vs. price of C$0.31 (27.1% above fair value)
  • GF Score™: 52/100 with 8 warning signs

No single metric tells the full story. See the TSX:MBX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBXBF:USA
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
52GF Score

Get the complete analysis for TSX:MBX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.31
Price
C$0.24
GF Value